Bausch & Lomb (TSX:BLCO) Accounts Payable : C$613 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Accounts Payable?

Bausch & Lomb's Accounts Payable for the quarter that ended in Mar. 2025 was C$613 Mil.

Bausch & Lomb's quarterly Accounts Payable declined from Sep. 2024 (C$616 Mil) to Dec. 2024 (C$554 Mil) but then increased from Dec. 2024 (C$554 Mil) to Mar. 2025 (C$613 Mil).

Bausch & Lomb's annual Accounts Payable increased from Dec. 2022 (C$503 Mil) to Dec. 2023 (C$700 Mil) but then declined from Dec. 2023 (C$700 Mil) to Dec. 2024 (C$554 Mil).

Bausch & Lomb Accounts Payable Historical Data

The historical data trend for Bausch & Lomb's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Accounts Payable Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

228.00

305.92

502.65

700.32

554.21

Bausch & Lomb Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial														576.63	555.05	616.34	554.21	613.00

Bausch & Lomb Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Bausch & Lomb Accounts Payable Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BLCO:USA

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives